摘要
Abstract
Objective:To study the mabthera in combination with chemotherapy in B cell non -hodgkin's lymphoma in clinical effect.Methods:our hospital from May 2010 to May 2012, 56 patients with B cell non-hodgkin's lymphoma were treated randomly divided into observation group and reference group, 28 cases in the observation group of patients in the chemotherapy with mabthera therapy at the same time, on the basis of the reference group of patients for chemotherapy treatment, compared two groups of clinical curative effect and adverse reaction of patients with what is happening,and 5 years survival rate.Results:The observation group of patients treatment effective rate was 92.9%, the reference group of patients treatment effective rate was 64.3%, two groups of data was more significant difference, P <0.05, there was statistical significance;Two groups of treatment of the patients with no serious adverse reaction occurred, P >0 .05 , no statistical significance.Observation group of patients within five years survival rate was 85.7%, the reference group 5 years survival rate was 53.6%, two groups of data comparison was statistically significant, P <0. 05, with statistical significance.Conclusion:B cell non-hodgkin's lymphoma patients'mabthera in combination with chemotherapy could improve the cure rate of patients, improve the prognosis of patients, and a lower incidence of adverse reactions, might be safe and effective, worth in clinical promotion.关键词
美罗华/化疗/B细胞非霍奇金淋巴瘤/临床效果Key words
Mabthera/Chemotherapy/B cell non-hodgkin's lymphoma/Clinical effect分类
医药卫生
